All articles by
Almirall, Microsoft partner to develop novel treatments for skin diseases
The three-year collaboration is aimed at advancing the digitalisation and technology to advance medical dermatology and develop next-generation personalised drugs, using generative artificial intelligence (genAI) and advanced analytics technologies
Biogen to stop development and commercialisation of Alzheimer’s drug Aduhelm
The company will return the licensing rights of the drug and terminate its post-marketing confirmatory ENVISION trial after it failed to find a partner to ease costs of securing standard regulatory approvals
Sandoz launches first and only biosimilar for multiple sclerosis, Tyruko, in Germany
Tyruko biosimilar to treat adults with highly active relapsing remitting multiple sclerosis (RRMS)
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
Designation is based on preliminary safety and efficacy data from an ongoing Phase 1/2 trial in patients with platinum-resistant ovarian epithelial cancer, fallopian tube, or primary peritoneal cancer
Astellas seeks approval for Padcev-Keytruda combo in Japan to treat bladder cancer
Astellas seeks approval from Japan’s MHLW for the combination therapy to treat adult patients with previously untreated locally advanced or metastatic urothelial cancer
Optimise healing with post-operative dressing change protocols
Operating in over 40 countries around the globe, Mölnlycke Health Care is a world-leading company that designs and supplies medical solutions to enhance performance in healthcare from the hospital to the home.
Combat the spread of infectious disease
The past few months has shown that a team’s rapid response to expediting an assay globally, dedicated to the detection of SARS-CoV-2, is possible. BioGX, in a long-term partnership with Becton, Dickinson and Company, has submitted a test to the FDA for emergency use authorisation (EUA) in the US, in parallel to CE-IVD approval. In these challenging times, laboratories around the world have an urgent need for an easy-to-use, reliable test to detect SARS-CoV-2 to determine if patients have contracted COVID-19. Authorisation to use these tests worldwide would increase access to highly reliable results.
Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections
Produced in the U.S., the generic anti-fungal drug is fully substitutable for Noxafil
FDA includes Deliberate AI’s depression and anxiety model in ISTAND programme
The AI-powered tool uses advanced multimodal behavioural signal processing and ML to collect mental health symptoms and offer a consistent, bias-free assessment method
EMA accepts review for Padcev with Keytruda in urothelial cancer
Pfizer and Astellas Pharma seek approval for Padcev with Keytruda as the first-line treatment of adult patients with previously untreated locally advanced or metastatic urothelial cancer